Blood clots form inside the heart when blood pools and stops moving normally, when the inner lining of the heart is damaged, or when the blood itself becomes more prone to clotting. These three factors, often working together, account for nearly every case of intracardiac thrombosis. The most common triggers are atrial fibrillation, heart attacks, and weakened heart muscle, though artificial heart valves and certain temporary heart conditions also carry significant risk.
Three Conditions That Allow a Clot to Form
Clot formation anywhere in the body, including inside the heart, comes down to three overlapping problems: sluggish or stagnant blood flow, damage to the tissue lining the blood vessel or heart chamber, and changes in the blood that make it clot more easily. In the heart specifically, this means structural changes like an enlarged chamber, direct injury to the heart wall from a heart attack, and activation of clotting proteins and platelets circulating in the bloodstream. When two or three of these conditions overlap, clot risk rises sharply.
Atrial Fibrillation: The Leading Cause
Atrial fibrillation (AFib) is the single most common reason blood clots form inside the heart. During AFib, the upper chambers of the heart quiver chaotically instead of contracting with a strong, rhythmic squeeze. Blood pools in a small pouch called the left atrial appendage, a finger-shaped pocket where flow is already sluggish even in a healthy heart. When the atrium fibrillates, emptying velocity in that pouch drops further, and stagnant blood begins to clot.
Over time, AFib also causes structural damage. The atrium gradually stretches and enlarges, the inner lining erodes, and the tissue underneath becomes infiltrated with scar-like fibers. These wall changes activate clotting proteins and inflammatory signals in the blood, compounding the risk created by stasis alone. This is why AFib-related clots are so dangerous: all three clot-forming conditions are present simultaneously. If a clot breaks free from the left atrial appendage, it can travel directly to the brain and cause a stroke.
Heart Attack and Wall Damage
A heart attack kills a section of heart muscle, and the dead tissue becomes a surface where clots readily attach. These are called mural thrombi because they form along the inner wall of the left ventricle, the heart’s main pumping chamber. The risk is highest when the heart attack affects the front wall or the apex (the pointed tip) of the ventricle, because these areas tend to become thin, stretched, and almost motionless after the injury.
The damaged section stops contracting, so blood swirls slowly or sits in place near the injured wall. Meanwhile, the exposed tissue triggers the clotting cascade. One study tracking patients with post-heart attack clots found that 16% experienced a clot-related event elsewhere in the body, such as a stroke, over about five years of follow-up. The risk is concentrated in the first weeks and months after the heart attack, which is why imaging and blood thinners are standard parts of post-heart attack care for high-risk patients.
Weakened Heart Muscle (Cardiomyopathy)
Any condition that weakens the heart’s pumping ability can set the stage for clots. When the left ventricle can’t squeeze forcefully enough, blood lingers inside the chamber instead of being ejected with each beat. The key measure here is ejection fraction, the percentage of blood pushed out with each contraction. A healthy heart ejects roughly 55% to 70% of its blood per beat. Clot risk climbs meaningfully once ejection fraction drops below 35%, and becomes especially high below 30%.
Several types of cardiomyopathy carry this risk. Dilated cardiomyopathy, where the ventricle stretches and thins like an overinflated balloon, is the most common. But temporary forms of heart weakness also qualify: takotsubo syndrome (sometimes called broken heart syndrome), peripartum cardiomyopathy that develops late in pregnancy or shortly after delivery, and heart muscle damage caused by chemotherapy drugs. In each case, the core problem is the same. A ventricle pumping weakly creates the stagnant blood flow that clots need to form.
If heart function improves and ejection fraction climbs back above 35%, and imaging confirms the clot has dissolved, blood-thinning treatment can often be stopped after three to six months.
Prosthetic Heart Valves
Mechanical heart valves are durable and effective, but their artificial surfaces are inherently prone to triggering clot formation. The body recognizes the foreign material and activates platelets and clotting proteins along the valve’s surface. People with mechanical valves take blood thinners for life, and the risk of clots increases sharply if those medications are interrupted or fall below effective levels.
Not all valve positions carry equal risk. A mechanical valve in the mitral position (between the left atrium and left ventricle) has a higher clot rate than one in the aortic position, partly because blood flow patterns differ at each site. The highest-risk group, with more than a 10% annual chance of a clot-related event, includes patients with a mechanical mitral valve or older-generation aortic valves. Additional factors like AFib, high blood pressure, diabetes, or age over 75 push the risk higher. Trigger events, such as an infection that ramps up the body’s clotting activity, can tip the balance even when someone is otherwise well-managed on blood thinners.
How Heart Clots Cause Harm
A clot sitting inside the heart doesn’t always produce symptoms on its own. Many are discovered incidentally on imaging ordered for another reason. The real danger comes when a clot, or a piece of one, breaks loose and travels through the bloodstream. A fragment leaving the left side of the heart enters the arterial system and can lodge in the brain (causing a stroke), the kidneys, the intestines, or the arteries supplying the arms or legs.
Symptoms depend entirely on where the clot ends up. A stroke may cause sudden weakness on one side of the body, slurred speech, or vision loss. A clot blocking an artery to a limb causes sudden pain, pallor, and loss of pulse. A clot that stays in the heart and grows large enough can obstruct blood flow within the chamber itself, producing shortness of breath, chest pressure, or fainting. In some cases, though, the first sign of a heart clot is the embolic event it causes somewhere else in the body.
How Heart Clots Are Detected
The primary tool for finding clots inside the heart is echocardiography, an ultrasound of the heart. A standard transthoracic echocardiogram (the probe pressed against the chest wall) detects left ventricular clots with about 94% sensitivity and 96% specificity, making it highly reliable for clots in the main pumping chamber. For clots in the left atrium, particularly in the left atrial appendage where AFib-related clots form, a transesophageal echocardiogram (where a small probe is guided down the throat to get closer to the heart) provides a much clearer view. Cardiac MRI is sometimes used as a follow-up when echocardiogram results are unclear, especially for small or layered clots that blend into the heart wall.
Who Faces the Highest Risk
The people most likely to develop a blood clot in the heart share one or more of these profiles: they have atrial fibrillation (especially if untreated or undertreated with blood thinners), they recently had a large heart attack affecting the front wall of the heart, they have heart failure with an ejection fraction below 35%, or they have a mechanical heart valve. Overlapping risk factors compound the danger. Someone with a mechanical aortic valve who also has AFib, for example, falls into a higher risk category than someone with the same valve and a normal heart rhythm.
Underlying conditions like uncontrolled high blood pressure, diabetes, obesity, and chronic inflammation also contribute by making the blood more prone to clotting and by accelerating the structural heart changes that slow blood flow. Active infections, including common ones like skin infections, can temporarily spike clotting activity enough to trigger clot formation in someone who was previously at the margin of risk.